Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage
PSAB
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to examine wether delayed cerebral ischemia can be predicted by ultrasound brain perfusion imaging in patients with aneurysmal subarachnoid hemorrhage (SAH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 15, 2012
CompletedFirst Posted
Study publicly available on registry
February 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedApril 6, 2012
April 1, 2012
2 years
February 15, 2012
April 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of perfusion
Detection of hypoperfusion (defined by 50% or more reduction in beta-value of comparing day 1. with day 5.) in one or more of four regions in one or both hemispheres before the detection of delayed ischemia after SAH in CCT.
Baseline, Day 5
Secondary Outcomes (2)
Correlation between perfusion parameters, clinical course and flow velocities
Day 1 to 90
Change of Perfusion
Baseline, Day 5
Study Arms (1)
Ultrasound Perfusion Imaging
Patient with subarachnoid hemorrhage.
Interventions
Sonographic unit Phillips IU 22, 5ml SonoVue ultrasound contrast agent per examination, Duration: 1h
Eligibility Criteria
Primary care clinic
You may qualify if:
- Aneurysmal subarachnoid hemorrhage, Hunt and Hess 0-5
- Informed consent
- Sufficient transtemporal acoustic window
- First examination within 48h after subarachnoid hemorrhage
- Minimum Age 18 years
You may not qualify if:
- Contraindication against computed tomographic scan
- Incompatibility against SonoVue™
- Acute respiratory distress syndrome
- Uncontrollable hypertensive crisis
- Severe pulmonary disease(pulmonary hypertension \> 90 mmHg)
- acute severe cardiac insufficiency (New York Heart Association IV)
- known right-left-shunt
- pregnancy and breastfeeding
- Substance dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, Asklepios Hospital North
Hamburg, Hamburg, 22417, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Günter Seidel, MD, Professor of Neurology
Asklepios Kliniken Hamburg GmbH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Professor of Neurology
Study Record Dates
First Submitted
February 15, 2012
First Posted
February 23, 2012
Study Start
January 1, 2012
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
April 6, 2012
Record last verified: 2012-04